Dr. Lal PathLabs Limited Statistics
Want to see IN:LALPATHLAB full AI Analyst Report?
Dr. Lal PathLabs Limited (LALPATHLAB) Stock Statistics & Valuation Metrics
Total Valuation
Dr. Lal PathLabs Limited has a market cap or net worth of INR 330.03B. The enterprise value is INR 319.67B.
- Market Cap
- INR 330.03B
- Enterprise Value
- INR 319.67B
Share Statistics
Dr. Lal PathLabs Limited has 167,848,820 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 167,848,820
- Owned by Insiders
- ―
- Owned by Institutions
- 7.86%
Financial Efficiency
Dr. Lal PathLabs Limited’s return on equity (ROE) is 0.20 and return on invested capital (ROIC) is 16.88%.
- Return on Equity (ROE)
- 0.20
- Return on Assets (ROA)
- 0.16
- Return on Invested Capital (ROIC)
- 16.88%
- Return on Capital Employed (ROCE)
- 0.23
- Revenue Per Employee
- 5.31M
- Profits Per Employee
- 969.65K
- Employee Count
- 5,206
- Asset Turnover
- 0.88
- Inventory Turnover
- 36.49
Valuation Ratios
The current PE Ratio of Dr. Lal PathLabs Limited is 57.81. Dr. Lal PathLabs Limited’s PEG ratio is 6.52.
- PE Ratio
- 57.81
- PS Ratio
- 11.11
- PB Ratio
- 12.33
- Price to FCF
- 177.84
- Price to Operating Cash Flow
- 104.43
- PEG Ratio
- 6.52
Income Statement
In the last 12 months, Dr. Lal PathLabs Limited had revenue of 27.63B and earned 5.05B in profits. Earnings per share was 30.24.
- Revenue
- 27.63B
- Gross Profit
- 11.61B
- Operating Income
- 6.21B
- Pretax Income
- 6.69B
- Net Income
- 5.05B
- EBITDA
- 8.54B
- Earnings Per Share (EPS)
- 30.24
Cash Flow
In the last 12 months, operating cash flow was 3.24B and capital expenditures -1.34B, giving a free cash flow of 1.90B billion.
- Operating Cash Flow
- 3.24B
- Free Cash Flow
- 1.90B
- Free Cash Flow per Share
- 11.30
Dividends & Yields
Dr. Lal PathLabs Limited pays an annual dividend of INR 5.00, resulting in a dividend yield of 0.81%
- Dividend Per Share
- INR 5.00
- Dividend Yield
- 0.81%
- Payout Ratio
- 33.49%
- Free Cash Flow Yield
- 0.56%
- Earnings Yield
- 1.72%
Stock Price Statistics
- Beta
- 0.53
- 52-Week Price Change
- 26.25%
- 50-Day Moving Average
- 1919.34
- 200-Day Moving Average
- 1655.41
- Relative Strength Index (RSI)
- 56.42
- Average Volume (3m)
- 18.22K
Important Dates
Dr. Lal PathLabs Limited upcoming earnings date is Feb 04, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 04, 2026
- Next Earnings Date
- Feb 04, 2027
- Ex-Dividend Date
- Jul 30, 2026
Financial Position
Dr. Lal PathLabs Limited as a current ratio of 3.48, with Debt / Equity ratio of 7.93%
- Current Ratio
- 3.48
- Quick Ratio
- 3.38
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.05
- Interest Coverage Ratio
- 27.22
Taxes
In the past 12 months, Dr. Lal PathLabs Limited has paid 1.59B in taxes.
- Income Tax
- 1.59B
- Effective Tax Rate
- 0.24
Enterprise Valuation
Dr. Lal PathLabs Limited EV to EBITDA ratio is 34.82, with an EV/FCF ratio of 173.37.
- EV to Sales
- 10.83
- EV to EBITDA
- 34.82
- EV to Free Cash Flow
- 173.37
- EV to Operating Cash Flow
- 101.46
Balance Sheet
Dr. Lal PathLabs Limited has INR 13.31B in cash and marketable securities with INR 0.00 in debt, giving a net cash position of INR 13.31B billion.
- Cash & Marketable Securities
- INR 13.31B
- Total Debt
- INR 0.00
- Net Cash
- INR 13.31B
- Net Cash Per Share
- INR 79.28
- Tangible Book Value Per Share
- INR 152.18
Margins
Gross margin is 54.60%, with operating margin of 23.59%, and net profit margin of 19.23%.
- Gross Margin
- 54.60%
- Operating Margin
- 23.59%
- Pretax Margin
- 25.50%
- Net Profit Margin
- 19.23%
- EBITDA Margin
- 31.11%
- EBIT Margin
- 25.25%
Analyst Forecast
The average price target for Dr. Lal PathLabs Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 16.71%
- EPS Growth Forecast
- 9.15%
Scores
- Smart Score
- ―
- AI Score
- 75
